Prime presents at: “GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress”

While glucagon-like peptide-1 (GLP-1) agonist medications are a popular approach to treating obesity, combining the use of this class of medications with lifestyle modifications may be the answer to both creating successful patient outcomes and managing health care spend. That’s the topic of a Sept. 11 discussion at the Hart Senate Office Building 902 in Washington D.C. Panelists will discuss research, possible policy implications and solutions, as well as share the strengths and limitations of GLP-1s as a tool to tackle the obesity epidemic.

Event:

GLP-1 Agonists + Food is Medicine: A New Recipe for Success in Treating Obesity? A Briefing for Congress

Date/time:

Wednesday, Sept. 11 | 12–1 p.m. ET

Moderator:

• Danielle Nierenberg, president and founder, Food Tank

Panelists:

• Dariush Mozaffarian, director, Tufts Food is Medicine Institute
• Pat Gleason, assistant vice president, health outcomes at Prime Therapeutics
• Others TBD